Key result
Central MR blockade prevents hypertension induced by glycyrrhizic acid or carbenoxolone in rats.
Answers are grounded in this paper and cite their sources.
The apparent mineralocorticoid excess syndrome of patients ingesting large amounts of licorice or its derivatives is thought to be caused by the antagonism by these compounds of the enzyme 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD). 11 beta-HSD inactivates cortisol and corticosterone, allowing the more abundantly produced glucocorticoids access to the mineralocorticoid receptor (MR) in the kidney, where they act as mineralocorticoids. We have found that the infusion of both glycyrrhizic acid, an active principle of licorice, and carbenoxolone, a synthetic analogue, into a lateral ventricle of the brain [intracerebroventricular (icv)] of a rat, at a dose less than that which has an effect when infused subcutaneously, produces hypertension. Furthermore, the hypertension produced by the oral administration of carbenoxolone or glycyrrhizic acid is blocked by the icv administration of RU 28318, an MR antagonist, at a dose below that which has an effect on blood pressure when infused subcutaneously. While the oral administration caused saline polydipsia and polyuria typical of chronic systemic mineralocorticoid excess, the icv licorice derivatives produced hypertension without affecting saline appetite. Sensitizing the rats to mineralocorticoid hypertension by renal mass reduction and increasing salt consumption was not necessary for the production of hypertension. These findings provide additional evidence for a central role in blood pressure control by mineralocorticoids that is distinct from their renal effects. They also suggest that more is involved in licorice-induced hypertension than only inhibition of 11 beta-HSD.
No takes yet. Share an insight, caveat, or question.
Gómez-Sánchez et al. (2006) studied Licorice-induced hypertension / apparent mineralocorticoid excess. Intracerebroventricular or oral glycyrrhizic acid and carbenoxolone (with or without icv RU 28318) vs. Subcutaneous infusion or mineralocorticoid receptor antagonist (RU 28318) blockade was evaluated on Development of hypertension / blood pressure elevation. Intracerebroventricular infusion of glycyrrhizic acid or carbenoxolone induced hypertension in rats, and central MR blockade with RU 28318 prevented hypertension from oral administration.
Synapse has enriched 10 related papers. Consider them for comparative context: